Coca-Cola (KO) Q4 2025 earnings review
Volume Stabilizes, But Pricing Engine Stalls
Coca-Cola delivered 5% organic revenue growth in Q4, meeting targets, but the composition of growth shifted dramatically. While unit case volume stabilized at +1%, the pricing engine that drove results for two years nearly halted—Price/Mix contribution collapsed to +1% from a ~6% trend in prior quarters. Reported operating income plunged 32% due to a massive $960M impairment charge for BODYARMOR, signaling continued integration struggles. Looking ahead, management guides for a return to algorithm in 2026 (EPS +7-8%), but the sudden loss of pricing power in international markets raises questions about the quality of the coming year's growth.
🐂 Bull Case
The home market remains a stronghold. North America delivered 1% volume growth and robust +4% pricing, driving 15% comparable currency-neutral operating income growth. This offsets weakness abroad.
Despite the headline noise from impairments, comparable operating margin expanded 40 basis points to 24.4%. The company continues to squeeze efficiency out of its operations even as top-line dynamics shift.
🐻 Bear Case
The drop in Price/Mix to +1% is alarming, driven by negative realization in EMEA (-3%) and Asia Pacific (-3%). If Coke loses its ability to price, it becomes entirely dependent on volume growth, which remains anemic at 1%.
A fresh $960M non-cash impairment charge for BODYARMOR—on top of a $760M charge in early 2024—suggests the $5.6B acquisition is failing to meet expectations amidst intensifying competition.
⚖️ Verdict: ⚪
Neutral. The underlying business is stable, and 2026 guidance (EPS +7-8%) suggests acceleration. However, the sudden deceleration in international pricing and the repeated massive writedowns on BODYARMOR dampen enthusiasm.
Key Themes
International Pricing Pressure
For quarters, Coke relied on strong pricing globally. In Q4, that dynamic reversed in key international segments. EMEA reported -3% Price/Mix and Asia Pacific -3% Price/Mix, attributed to 'unfavorable mix' and timing. This dragged consolidated Price/Mix down to just 1%, the lowest level in over a year.
BODYARMOR & Portfolio Impairments
The company recorded a $960M impairment charge for the BODYARMOR trademark in Q4, citing 'slowing projected long-term growth' and an 'intensifying competitive environment.' This follows a $760M charge in 2024. The inability to stabilize this major acquisition is a significant drag on reported GAAP results ($1.8B operating income vs $2.7B prior year).
Latin America Momentum
Latin America remains a standout performer. The segment delivered balanced growth with +2% volume and +6% Price/Mix. Comparable currency-neutral operating income surged 13%, proving the region can handle pricing actions without sacrificing volume demand.
Asia Pacific Profit Squeeze
Asia Pacific is struggling. Volume was flat, but Price/Mix fell 3%, leading to a sharp 36% decline in reported Operating Income. Even on a comparable currency-neutral basis, operating income fell 3%, driven by higher input costs that pricing failed to offset.
Zero Sugar Portfolio
Coca-Cola Zero Sugar continues to defy gravity, growing volume 13% in the quarter (and 14% for the full year). This structural mix shift toward higher-margin, premium products is a key buffer against the volume sluggishness seen in the broader sparkling category (flat volume).
Other KPIs
Stable. Grew 6% YoY, in line with the full-year trend (FY25 +4%). Despite the pricing headwinds and currency impact (5 points), the company managed to deliver bottom-line growth through cost discipline.
Distorted. The number appears low compared to FY24 ($9.7B excluding tax deposit) due to a massive $6.1B contingent payment for fairlife made in Q1. Excluding this payment, underlying Free Cash Flow was robust at $11.4B, showing strong cash conversion.
Decelerating violently from 25.9% a year ago due to the impairment charge. However, Comparable Operating Margin remains healthy, supported by 4% pricing growth.
Guidance
Stable. This aligns with the company's long-term algorithm and matches the 5% achieved in FY25. It implies management expects the Q4 pricing weakness to normalize or volume to pick up slightly.
Accelerating. This is a step up from the +4% Comparable EPS growth delivered in FY25. The guidance includes an estimated 3% currency tailwind, a reversal from the headwinds faced in 2025.
Stable/Growing. Represents a healthy conversion from operations, free of the massive one-off payments (Tax deposit, fairlife) that obscured statutory cash flow in '24 and '25.
Key Questions
Pricing Power Disappearance
Price/Mix dropped to +1% this quarter after running at +6% for most of the year. Was this purely 'timing of shipments' as stated, or are you seeing a structural ceiling on pricing in EMEA and Asia?
BODYARMOR Viability
With nearly $1.7B in impairments recorded over the last two years, do you still see a path for BODYARMOR to be a growth accretive asset, or is it entering managed decline?
Asia Pacific Margins
Comparable currency-neutral operating income in APAC declined 3% due to input costs. When do you expect the price-cost spread in this region to turn positive again?